Glutathione as a Potential Neuroprotectant Against MDMA-Induced Oxidative Stress, Neuroinflammation, and Apoptosis in

Oyedayo Phillips Akano1, Goodness Olatinwo2, Moses Agbomhere Hamed3

  • 1Department of Physiology, Faculty of Basic Medical Sciences, Olabisi Onabanjo University, Ago Iwoye, Ogun State, Nigeria.

Insights

Glutathione offers partial neuroprotection against MDMA-induced neurotoxicity in rats, particularly at lower doses by reducing oxidative stress and inflammation. Its effectiveness is limited at higher MDMA concentrations, indicating a need for combined therapies.

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • 3,4-Methylenedioxymethamphetamine (MDMA) causes neurotoxicity via oxidative stress, inflammation, and apoptosis.
  • Glutathione, an endogenous antioxidant, is investigated for its neuroprotective potential against MDMA damage.

Purpose of the Study:

  • To evaluate the neuroprotective effects of glutathione against MDMA-induced neurotoxicity in a rat model.
  • To assess the impact of combined MDMA and glutathione administration on oxidative stress, inflammation, neurotransmitter levels, and apoptosis in the brain.

Main Methods:

  • Adult male Wistar rats were administered MDMA (5 or 15 mg/kg) and/or glutathione (15 mg/kg) orally for 56 days.
  • Brain tissues were analyzed for oxidative stress markers, inflammatory cytokines, ion transport enzymes, neurotransmitters, and apoptosis.
  • Histological examination of the hippocampus was performed.

Main Results:

  • MDMA increased oxidative stress (MDA, 8-OHdG), inflammation (MPO, NF-κB, TNF-α), and apoptosis (caspase-3), while decreasing antioxidant enzymes and disrupting ion homeostasis.
  • Neurotransmitter imbalances (altered dopamine, serotonin, AChE) were observed with MDMA exposure.
  • Glutathione partially reversed MDMA-induced damage at lower doses but showed limited efficacy at higher MDMA concentrations.

Conclusions:

  • Glutathione provides partial neuroprotection against MDMA toxicity by restoring redox balance and reducing inflammation, especially at moderate MDMA exposure levels.
  • The therapeutic potential of glutathione is limited under high-dose MDMA exposure, suggesting the need for complementary therapeutic strategies.